Inventor
BRYANT MARTIN L
US22 patents
⚠️ This page may combine multiple inventors who share the name “BRYANT MARTIN L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDENIX PHARMACEUTICALS INC
8 patentsUS6875751B2Apr 5, 2005
3′-prodrugs of 2′-deoxy-β-L-nucleosides
IDENIX PHARMACEUTICALS INC131 citations99
US6569837B1May 27, 2003
β-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis B
IDENIX PHARMACEUTICALS INC98 citations99
US6566344B1May 20, 2003
β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
IDENIX PHARMACEUTICALS INC122 citations99
US7585851B2Sep 8, 2009
3′-prodrugs of 2′-deoxy-β-L-nucleosides
IDENIX PHARMACEUTICALS INC69 citations98
US6787526B1Sep 7, 2004
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
IDENIX PHARMACEUTICALS INC93 citations98
US6596700B2Jul 22, 2003
Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosides
IDENIX PHARMACEUTICALS INC61 citations96
US7304043B2Dec 4, 2007
β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
IDENIX PHARMACEUTICALS INC8 citations74
US7795238B2Sep 14, 2010
β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
IDENIX PHARMACEUTICALS INC3 citations63
SEARLE & CO
5 patentsUS5622972AApr 22, 1997
Method for treating a mammal infected with respiratory syncytial virus
SEARLE & CO73 citations96
US6545021B1Apr 8, 2003
Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
SEARLE & CO56 citations92
US6100277AAug 8, 2000
Retroviral protease inhibitor combinations
SEARLE & CO27 citations85
US6515028B1Feb 4, 2003
Glucamine compounds for treating hepatitis virus infections
SEARLE & CO13 citations84
US6747149B2Jun 8, 2004
Glucamine salts for treating hepatitis virus infections
SEARLE & CO0 citations52